Detalles de la búsqueda
1.
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease.
Br J Clin Pharmacol
; 89(5): 1656-1664, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494329
2.
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
Am J Respir Crit Care Med
; 201(9): 1135-1145, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31917607
3.
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy.
Sleep
; 43(4)2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31626696
4.
Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study.
Sleep
; 42(11)2019 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31529094
5.
A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment.
Orphanet J Rare Dis
; 10: 74, 2015 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26070802
6.
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.
Sci Rep
; 5: 7608, 2015 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25566747
7.
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Orphanet J Rare Dis
; 9: 199, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25519680
8.
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Orphanet J Rare Dis
; 11(1): 92, 2016 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27387831
Resultados
1 -
8
de 8
1
Próxima >
>>